McDermott Will & Emery
Subscribe to McDermott Will & Emery's PostsLife Sciences Dealmaking Symposium: As the Dust Settles: Post-Election Update and Impact on the Life Sciences Industry
By McDermott Will & Emery on Dec 11, 2020
Posted In Digital Health, Life Sciences
How will the election affect life sciences in 2021 and beyond? What’s ahead for the regulatory and policy environment? In this session, our elite group of policy analysts reviewed the election results and the far-reaching effects for dealmakers, executives and investors. Eric Zimmerman, global head of McDermott’s Health Industry Advisory Practice Group, moderated this discussion...
Continue Reading
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
By McDermott Will & Emery on Dec 11, 2020
Posted In Digital Health, Life Sciences
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in...
Continue Reading
Life Sciences Dealmaking Symposium: New Factors in the Mix: Diligence in the Time of COVID-19
By McDermott Will & Emery on Dec 11, 2020
Posted In Digital Health, Life Sciences
Navigating the ever-changing global life sciences deal landscape has become more challenging in the post-pandemic world. Conducting virtual inspections and examining security and privacy risks for remote working and new operating procedures will be central to evaluating current and future collaboration partners and targets. Thinking quickly yet carefully is essential for successfully adapting to this...
Continue Reading
Hospital and Health System Innovation Summit: Lessons Learned: Diligence, Detours and Data, Oh My
By McDermott Will & Emery on Nov 20, 2020
Posted In Health M&A, Hospitals & Health Systems
Industry leaders shared first-hand lessons learned from their work on recent innovation related projects. We covered a range of case studies, highlighting lessons learned around mission alignment, conflicts of interest, diligence considerations, data ownership and de-identification, and strategies for protecting a minority investor. Below are the top takeaways for Hospital and Health System Innovation Summit:...
Continue Reading
Hospital and Health System Innovation Summit: Pandemic to Partnership: The Impact of Covid-19 on Innovation
By McDermott Will & Emery on Nov 20, 2020
Posted In Uncategorized
In this interactive discussion, health system innovation leaders addressed the impact of COVID-19 on health systems’ plans to pursue innovation efforts; the lasting implications of the pandemic; and the prioritization of innovation efforts and investments post-COVID-19. McDermott Will and Emery’s Partner Kerrin B. Slattery moderated this discussion featuring insights from Lisa Prasad, Vice President and...
Continue Reading
Hospital and Health System Innovation Summit: Nuts And Bolts: How to Invest in Innovation
By McDermott Will & Emery on Nov 20, 2020
Posted In Health M&A, Hospitals & Health Systems
There has been increased interest by hospitals and health systems in creating innovation centers and making innovation center investments, which are helping to transform the healthcare landscape. As they enter this space, hospitals and health systems must first decide how to organize to capitalize on and commercialize innovation opportunities to get innovations into the routine...
Continue Reading
Policy Outlook: How The 2020 Election Outcomes Will Impact Your Business – Health Policy
By McDermott Will & Emery on Nov 6, 2020
Posted In Health M&A, Health Private Equity, Hospital Health Benefits
In this session, health law policy authorities discussed changes likely in 2021 in a Biden Administration and how these changes will impact business objectives and strategies for health industry stakeholders. Below are the top takeaways for Policy Outlook: How The 2020 Election Outcomes Will Impact Your Business session: Health, click here to access the full...
Continue Reading
HPE New York 2020: Big Bankers Breakfast Discussion
By McDermott Will & Emery on Nov 6, 2020
Posted In Health M&A, Health Private Equity, Life Sciences
In this lively panel session, global heads of healthcare at top banks analyzed the current market climate for healthcare services investing and provided their invaluable insights on hot sectors, growth strategies and the dealmaking outlook for 2021. McDermott counsel Charlie Ditkoff moderated this panel featuring Daniel Decelles, global co-head of healthcare investment banking at Jefferies;...
Continue Reading
HPE New York 2020: The Impact of COVID-19: What’s Hot, What’s Not
By McDermott Will & Emery on Nov 6, 2020
Posted In Health M&A, Health Private Equity, Life Sciences, Uncategorized
In the wake of COVID-19 some health sectors have emerged as hot while others are troubled. Our panel of active investors discussed where the dollars are going and offered insights on why in relation to the events of 2020. McDermott partner Jerry Sokol moderated this dynamic panel featuring Paige Daly, partner at Harvest Partners; Chris...
Continue Reading
HPE New York 2020: Healthcare Private Equity Pioneers
By McDermott Will & Emery on Nov 5, 2020
Posted In Health Private Equity, PPM/ASC, Uncategorized
An illustrious group of healthcare private equity pioneers discussed how healthcare investing has evolved from inception to current state and what the future holds. Moderated by Michael Lewis, author of The Big Short, Moneyball, The Blind Side and Liar’s Poker, it featured insights from Senator Bill Frist, MD, founder of Frist Cressey Ventures; Annie Lamont,...
Continue Reading
